2022年

論文

消化器内科

英文

1. Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital-based population.
   Ando Y, Kumamoto K, Matsukawa H, Ishikawa R, Suto H, Oshima M, Kamada H, Morishita A, Kobara H, Matsunaga T, Haba R, Masaki T, Suzuki Y, Okano K.
   Oncol Lett　23(1): 4, 2022
2. Endoscopic ligation with O-ring closure for a large artificial defect after rectal endoscopic submucosal dissection.
   Tada N, Kobara H, Nishiyama N, Masaki T.
   Dig Liver Dis　54(1): 142-143, 2022
3. Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.
   Hirata M, Fujita K, Fujihara S, Mizuo T, Nakabayashi R, Kono T, Namima D, Fujita N, Yamana H, Kamada H, Tani J, Kobara H, Tsutsui K, Matsuda Y, Ono M, Masaki T.
   In Vivo　36(1): 94-102, 2022
4. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study.
   Matsumoto K, Ohfuji S, Abe M, Komori A, Takahashi A, Fujii H, Kawata K, Noritake H, Tadokoro T, Honda A, Asami M, Namisaki T, Ueno M, Sato K, Kakisaka K, Arakawa M, Ito T, Tanaka K, Matsui T, Setsu T, Takamura M, Yasuda S, Katsumi T, Itakura J, Sano T, Tamura Y, Miura R, Arizumi T, Asaoka Y, Uno K, Nishitani A, Ueno Y, Terai S, Takikawa Y, Morimoto Y, Yoshiji H, Mochida S, Ikegami T, Masaki T, Kawada N, Ohira H, Tanaka A.
   J Gastroenterol　57(1): 19-29, 2022
5. Can microRNA-96-5p serve as a therapeutic molecule in the near future?
   Masaki T, Tani J, Morishita A.
   Hepatol Res　52(1): 3-4, 2022
6. Hepatocellular carcinoma induces body mass loss in parallel with osmolyte and water retention in rats.
   Kidoguchi S, Kitada K, Nakajima K, Nakano D, Ohsaki H, Kittikulsuth W, Kobara H, Masaki T, Yokoo T, Takahashi K, Titze J, Nishiyama A.
   Life Sci　289: 120192, 2022
7. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines.
   Takuma K, Fujihara S, Fujita K, Iwama H, Nakahara M, Oura K, Tadokoro T, Mimura S, Tani J, Shi T, Morishita A, Kobara H, Himoto T, Masaki T.
   Int J Mol Sci　23(3): 1667, 2022
8. Ampullary carcinoma of the duodenum: current clinical issues and genomic overview.
   Okano K, Oshima M, Suto H, Ando Y, Asano E, Kamada H, Kobara H, Masaki T, Suzuki Y.
   Surg Today　52(2): 189-197, 2022
9. Influence of gender on diaphragm thickness using a method for determining intima media thickness in healthy young adults.
   Oguri M, Okanishi T, Ikeguchi T, Ogo K, Kanai S, Maegaki Y, Wada S, Himoto T.
   BMC Med Imaging　22(1): 26, 2022
10. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
    Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (Hepatocellular Carcinoma Experts from 48 Clinics in Japan).
    Cancer Rep (Hoboken)　5(2): e1464, 2022
11. Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient.
    Okano Y, Kunishige M, Kondo Y, Kadota N, Morishita A, Naruse K, Machida H, Hatakeyama N, Hino H, Shinohara T, Sakiyama S, Takeuchi E.
    Thorac Cance　13(3): 510-513, 2022
12. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    Morishita A, Tadokoro T, Fujihara S, Iwama H, Oura K, Fujita K, Tani J, Takuma K, Nakahara M, Shi T, Haba R, Okano K, Nishiyama A, Ono M, Himoto T, Masaki T.
    PLoS One　17(2): e0261310, 2022
13. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
    Hamaya S, Fujihara S, Iwama H, Fujita K, Shi T, Nakabayashi R, Mizuo T, Takuma K, Nakahara M, Oura K, Tadokoro T, Mimura S, Tani J, Morishita A, Kobara H, Ono M, Himoto T, Masaki T.
    Anticancer Res　42(3): 1263-1275, 2022
14. An Evaluation of Endoscopic Images from Over 15 Years Prior to the Diagnosis of Autoimmune Gastritis: A Report of Three Patients.
    Ayaki M, Manabe N, Murota M, Fujita M, Haruma K.
    Intern Med　61(6): 827-833, 2022
15. Role of Short-Term Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer.
    Okano K, Suto H, Oshima M, Ando Y, Matsukawa H, Kamada H, Kobara H, Masaki T, Suzuki Y.
    Am Surg　in press
16. Long-term outcomes of over-the-scope clip for refractory gastrointestinal diseases.
    Goda Y, Kobara H, Kobayashi N, Nishiyama N, Fujihara S, Tada N, Kozuka K, Matsui T, Chiyo T, Shi T, Fujita K, Tani J, Yachida T, Takata M, Okano K, Nakano D, Nishiyama A, Mori H, Masaki T.
    Minim Invasive Ther Allied Technol　in press
17. Surgical management and outcomes of obstructive colorectal cancer in elderly patients: A multi-institutional retrospective study.
    Kondo A, Okano K, Kumamoto K, Kobara H, Nagahara T, Wato M, Shibatoge M, Minato T, Masaki T, Suzuki Y; Kagawa Gastroenterology Forum.
    Surgery　in press
18. Dual-functional use of thread delivery hood for traction-assisted rectal endoscopic submucosal dissection and defect closure.
    Kobayashi N, Kobara H, Kozuka K, Tada N, Matsui T, Nishiyama N, Masaki T.
    Endoscopy　in press
19. Repeated balloon inflation under low pressure may reduce serious adverse events during endoscopic papillary large balloon dilation.
    Kamada H, Kobara H, Yamana H, Fujita N, Daisuke N, Toshiaki K, Masahiro H, Ryota N, Okano K, Masaki T.
    J Hepatobiliary Pancreat Sci　in press
20. Endoscopic mucosal resection under gel immersion for superficial nonampullary duodenal epithelial neoplasms.
    Yachida T, Kobara H, Tada N, Nishiyama N, Takata T, Masugata H, Masaki T.
    Endoscopy　in press
21. Miniature-probe endoscopic ultrasonography using a rubber balloon to evaluate gastrointestinal carcinomas in poor underwater conditions.
    Kobayashi N, Kobara H, Nishiyama N, Shi T, Chiyo T, Yachida T, Masaki T.
    Endoscopy　in press
22. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
    Matsuda Y, Yamashita T, Ye J, Yasukawa M, Yamakawa K, Mukai Y, Machitani M, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Yamada S, Takei J, Kaneko MK, Kojima M, Kaneko S, Masaki T, Hirata M, Haba R, Kontani K, Kanaji N, Miyatake N, Okano K, Kato Y, Masutomi K.
    J Pathol　in press
23. Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-Based Cohort Study.
    Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
    Clin Gastroenterol Hepatol　in press
24. Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
    Atsukawa M, Tsubota A, Kondo C, Toyoda H, Nakamuta M, Takaguchi K, Watanabe T, Hiraoka A, Uojima H, Ishikawa T, Iwasa M, Tada T, Nozaki A, Chuma M, Fukunishi S, Asano T, Ogawa C, Abe H, Kato K, Hotta N, Shima T, Matsuura K, Mikami S, Tachi Y, Fujioka S, Okubo H, Shimada N, Tani J, Morishita A, Hidaka I, Moriya A, Tsuji K, Akahane T, Okubo T, Arai T, Kitamura M, Morita K, Kawata K, Tanaka Y, Kumada T, Iwakiri K; KTK49 Liver Study Group.
    Hepatol Res　in press
25. Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC-B stage patients classified as beyond up to seven criteria – Multicenter analysis.
    Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (Hepatocellular Carcinoma Experts from 48 Clinics in Japan.
    Hepatol Res　in press
26. Neutrophil-lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis.
    Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y; Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group.
    Eur J Gastroenterol Hepatol　in press
27. Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
    Hatanaka T, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Kakizaki S, Shimada N, Kawata K, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Naganuma A, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y, Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).
    Hepatol Res　in press
28. Wafer paper and ring-mounted polyglycolic acid sheet method for shielding artificial gastric floor.
    Kobayashi N, Kobara H, Nishiyama N, Fujihara S, Kozuka K, Tada N, Matsui T, Chiyo T, Takata T, Fujita K, Tani J, Yachida T, Okano K, Nakano D, Nishiyama A, Mori H, Masaki T.
    Minim Invasive Ther Allied Technol　in press
29. Beige mucosa observable under narrow-band imaging indicates the active sites of eosinophilic esophagitis.
    Ayaki M, Manabe N, Tomida A, Tada N, Mastunaga T, Murota M, Fujita M, Katsumata R, Kobara H, Masaki T, Haruma K.
    J Gastroenterol Hepatol　in press
30. Efficacy of endoscopic ligation with O-ring closure for preventing gastric post- ESD bleeding under antithrombotic therapy: A prospective observational study.
    Nishiyama N, Kobara H, Kobayashi N, Chiyo T, Tada N, Kozuka K, Matsui T, Yachida T, Fujihara S, Shi TT, Masaki T.
    Endoscopy　in press
31. Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy.
    Suto H, Okano K, Oshima M, Ando Y, Matsukawa H, Takahashi S, Shibata T, Kamada H, Masaki T, Suzuki Y.
    J Surg Oncol　in press
32. A Retrospective Study of the Differences in the Induction of Regulatory T Cells Between Adult Patients with Eosinophilic Esophagitis and Gastroesophageal Reflux Disease.
    Ayaki M, Manabe N, Nakamura J, Fujita M, Katsumata R, Haruma K.
    Dig Dis Sc　in press

脳神経内科

英文

1. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
   Nonaka W, Takata T, Iwama H, Komatsubara S, Kobara H, Kamada M, Deguchi K, Touge T,Miyamoto O, Nakamura T, Itano T, Masaki T.
   Mol Med Rep　25(3): 88, 2022
2. Porencephaly causing limb size asymmetry.
   Takata T, Kume K, Kobara H, Deguchi K, Masaki T.
   Acta Neurol Belg　in press
3. Significance of Cortical Ribboning as a Biomarker in the Prodromal Phase of Sporadic Creutzfeldt
   Jakob Disease.
   Hamada Y, Deguchi K, Tachi K, Kita M, Nonaka W, Takata T, Kobara H, Touge T, Satoh K, Masaki T.
   Intern Med　in press

消化器内科

和文

1. 消化器内視鏡用ウイルス感染防御システムのデザイン
   大場晴夫、西山典子、永冨太一、安藤啓次、福元隆広、小原英幹
   デザイン学研究作品集　27(1): 12-17, 2022
2. 鳥取県内の一般診療所における生理機能検査を担当する臨床検査技師の実態調査
   大栗聖由、上原一剛、池亀彰茂、小河佳織、樋本尚志、前垣義弘、吉岡伸一
   医学調査　71(2): 342-348, 2022
3. 消化器内視鏡用ウイルス感染防御システムのデザイン
   大場晴夫、西山典子、永冨太一、安藤啓次、福元隆広、小原英幹
   デザイン学研究作品集　27(1): 12-17, 2022

脳神経内科

学会

国際学会

消化器内科

1. A new therapeutic strategy using cell-free DNA that predicts drug resistance of Atezolizumab plus bevacizumab for the treatment of advanced hepatocellular carcinoma.
   Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tsutomu Masaki.
   The 31st Conference of the Asian Pacific Assocication for the Study of he Liver(APASL2022)　2022.3.30-4.3, SEOUL+Web
2. Long-term outcomes and evaluation of HCC recurrence after HCV eradication by DAA treatment.
   Joji Tani, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Asahiro Morishita, Masahiro Ono, Tsutomu Masaki.
   The 31st Conference of the Asian Pacific Assocication for the Study of he Liver(APASL2022)　2022.3.30-4.3, SEOUL+Web
3. Usefulness of serum angiogenic molecules as predictive biomarkers of the early disease progression in atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma.
   Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tsutomu Masaki.
   The 31st Conference of the Asian Pacific Assocication for the Study of he Liver(APASL2022)　2022.3.30-4.3, SEOUL+Web

脳神経内科

全国学会

消化器内科

1. 消化管診断学の新展開【胃疾患の内視鏡診断・病理診断の最前線】
   非萎縮胃粘膜上に発現する白点と制酸剤、高ガストリン血症との関連性
   西山典子、小原英幹、正木　勉
   第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
2. 胃腫瘍内視鏡治療における工夫
   内視鏡的全層縫合における手技法別縫合力に関するブタ切除胃を用いた基礎系検証試験
   松井崇矩、西山典子、小林伸也、川西竜輔、小塚和博、多田尚矢、千代大翔、谷内田達夫、内多訓久、平澤欣吾、小原英幹
3. 第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
   十二指腸腫瘍内視鏡治療における工夫
   ビスコクリアを用いた表在型十二指腸非乳頭部上皮性腫瘍に対する Undergel EMR は術野確保に有効か？
   谷内田達夫、小原英幹、多田尚矢、小塚和博、松井崇矩、千代大翔、小林伸也、西山典子、舛形　尚、正木　勉
   第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
4. 食道疾患に対する内視鏡治療の工夫
   クリスタルバイオレットを用いた食道粘膜下トンネルの遠位側終点同定法の有用性
   千代大翔、小原英幹、西山典子、多田尚矢、小塚和博、松井崇矩、合田康宏、小林伸也、藤原新太郎、谷内田達夫、正木　勉
   第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
5. 大腸腫瘍内視鏡治療における工夫
   0-ringとナイロン糸を用いた粘膜筋層把持縫縮法の直腸ESD後創面に対する有効性の検討：Endoscopic liga­tion with 0-ring closure
   多田尚矢、西山典子、小原英幹、小塚和博、松井崇矩、千代大翔、小林伸也、谷内田達夫、正木　勉
   第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
6. 消化管出血に対する診療の進歩
   難治性腫瘍出血に対するポリグリコール酸シート貼付の出血制御効果
   小林伸也、小原英幹、小塚和博、川西竜輔、多田尚矢、松井崇矩、千代大翔、西山典子、谷内田達夫、正木　勉
   第18回日本消化管学会総会学術集会　2022.2.11-12, 東京+Web
7. 臨床研究2
   非アルコール性脂肪性肝疾患患者における血中微量元素濃度と相関する因子の検索
   樋本尚志、山口　颯、前場隆志、正木　勉
   第24回日本病院総合診療医学会学術総会　2022.2.26-27, Web
8. LEDキャンドルがもたらす睡眠への効果
   その1～脳波などの生理的指標を用いた検証～
   小山泰輔、好川千尋、市川美里、藤沢　柚、堀美紀子、大栗聖由、小河佳織、多田達史、樋本尚志
   日本看護研究会学会中国・四国地方会第35回学術集会　2022.3.6-20, Web
9. LEDキャンドルがもたらす睡眠への効果
   その2～OSA睡眠調査票を用いた生活の場での適応性の検討～
   市川美里、藤沢　柚、小山泰輔、好川千尋、堀美紀子、大栗聖由、小河佳織、多田達史、樋本尚志
   日本看護研究会学会中国・四国地方会第35回学術集会　2022.3.6-20, Web

脳神経内科

地方会

消化器内科

1. 第31回日本消化器内視鏡学会四国セミナー　2022.1.9, Web
   胆膵疾患におけるEUSの役割
   鎌田英紀

脳神経内科